S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q3 2021

BVF Partners

Periodo: Q3 2021 Β· Depositato: 2021-11-15
Vedi su SEC EDGAR β†—
AUM
$2.56B
Valore totale del portafoglio
Posizioni
75
Titoli dichiarati
Prima Posizione
GHRS
8.0% $204.6M
Var. Trimestrali
+8 / -5
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-11-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GHRSGH RESEARCH PLC$204.6M7.98%$22.06$27.01+22.4%
8.0%
KYMRKYMERA THERAPEUTICS INC$186.8M7.29%$58.74$113.51+93.2%
7.3%
OLMAOLEMA PHARMACEUTICALS INC$183.6M7.16%$27.56$12.64-54.1%
7.2%
RCUSARCUS BIOSCIENCES INC$112.6M4.39%$34.87$30.33-13.0%
4.4%
MERUS N V$111.3M4.34%β€”β€”
4.3%
ARGXARGENX SE$110.6M4.31%$302.00$939.68+211.2%
4.3%
RPTXREPARE THERAPEUTICS INC$97.7M3.81%β€”β€”
3.8%
XOMAXOMA CORP DEL$87.4M3.41%$24.75$43.00+73.7%
3.4%
PTGXPROTAGONIST THERAPEUTICS INC$69.1M2.70%$17.72$131.62+642.8%
2.7%
LXRXLEXICON PHARMACEUTICALS INC$69.1M2.69%$4.81$2.32-51.8%
2.7%
RVMDREVOLUTION MEDICINES INC$68.4M2.67%$27.51$189.24+587.9%
2.7%
RLAYRELAY THERAPEUTICS INC$64.6M2.52%$31.53$18.65-40.9%
2.5%
LKFTGALAPAGOS NV$58.9M2.30%$52.61$30.39-42.2%
2.3%
AMRNXXXXAMARIN CORP PLC$58.2M2.27%β€”β€”
2.3%
FDMT4D MOLECULAR THERAPEUTICS IN$54.1M2.11%$26.97$13.00-51.8%
2.1%
SNDXSYNDAX PHARMACEUTICALS INC$47.5M1.85%$19.11$21.82+14.2%
1.9%
ACIUAC IMMUNE SA$46.5M1.82%$6.71$2.51-62.6%
1.8%
VSTMXXXXVERASTEM INC$46.1M1.80%β€”β€”
1.8%
RAINRAIN THERAPEUTICS INC$44.3M1.73%β€”$1.97
1.7%
WHWKAADI BIOSCIENCES INC$33.7M1.31%$29.37$4.19-85.7%
1.3%
SPROSPERO THERAPEUTICS INC$33.3M1.30%$18.41$2.20-88.0%
1.3%
KURAKURA ONCOLOGY INC$30.6M1.19%$18.73$11.10-40.7%
1.2%
TYRATYRA BIOSCIENCES INC$29.8M1.16%$17.59$30.62+74.1%
1.2%
INFIQINFINITY PHARMACEUTICALS INC$28.7M1.12%$3.42$0.00
1.1%
PIRSPIERIS PHARMACEUTICALS INC$27.6M1.07%β€”β€”
1.1%
REPLREPLIMUNE GROUP INC$27.5M1.07%$29.64$11.58-60.9%
1.1%
CTICCTI BIOPHARMA CORP$26.3M1.03%β€”β€”
1.0%
VIRXVIRACTA THERAPEUTICS INC$24.8M0.97%β€”β€”
1.0%
ACRSACLARIS THERAPEUTICS INC$24.7M0.96%$18.00$5.56-69.1%
1.0%
XENEXENON PHARMACEUTICALS INC$24.0M0.94%$15.28$60.96+298.9%
0.9%

AttivitΓ  Trimestre su Trimestre

Q3 2021 vs. Q2 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
MERUS N V$111.3M
LKFTGALAPAGOS NV$58.9M-42.2%
WHWKAADI BIOSCIENCES INC$33.7M-85.7%
TYRATYRA BIOSCIENCES INC$29.8M+74.1%
PNTPOINT BIOPHARMA GLOBAL INC$21.3M
ALPNALPINE IMMUNE SCIENCES INC$17.0M
NUVLNUVALENT INC$10.1M
MIRMMIRUM PHARMACEUTICALS INC$8.7M

Posizioni Chiuse (5)

TickerEmittenteNozionale
MRUSMERUS N V$153.5M
RACATHERAPEUTICS ACQUISITION COR$28.5M
FBRXFORTE BIOSCIENCES INC$19.9M
IMVTIMMUNOVANT INC$13.5M
CNTACENTESSA PHARMACEUTICALS PLC$1.3M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CRNXCRINETICS PHARMACEUTICALS IN$19.6M+3828.7%
AMRNXXXXAMARIN CORP PLC$50.7M+564.8%
IVAINVENTIVA SA$6.3M+408.9%
VRDNVIRIDIAN THERAPEUTICS INC$6.8M+129.7%
LXRXLEXICON PHARMACEUTICALS INC$30.5M+71.1%-51.8%
RAINRAIN THERAPEUTICS INC$14.0M+52.0%
ACRSACLARIS THERAPEUTICS INC$7.2M+37.3%-69.1%
VSTMXXXXVERASTEM INC$0.2M+32.7%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RNACSELECTA BIOSCIENCES INC$-5.8M-81.1%
CRVSCORVUS PHARMACEUTICALS INC$-3.2M-62.7%
ANABANAPTYSBIO INC$-11.9M-58.7%
ARGXARGENX SE$-85.5M-43.8%+211.2%
RLAYRELAY THERAPEUTICS INC$-42.9M-30.3%-40.9%
ACIUAC IMMUNE SA$-21.2M-18.8%-62.6%
FWPAYFORWARD PHARMA A/S$-1.6M-18.1%
GRTSQGRITSTONE BIO INC$-0.2M-16.3%
← Torna agli Hedge Fund